Atlas Trials

Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.

Clinical trial NCT02890719 · WITHDRAWN

Trial details

NCT number
NCT02890719
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Liver TransplantationHepatitis C
Start date
2016-08-03
Primary completion
2017-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.